Alexza Pharmaceuticalsa Subsidiary Of Ferrer Therapeutics Inc Is Based In Mountain Viewcaliforniathe Company Specializes In Developing And Commercializing Treatments For Acute Central Nervous Systemcnsconditions Using Its Proprietary Staccatoasystema Hand Held Inhaler Technologysince Its Acquisition By Ferrer In 2016Alexza Has Focused On Bringing Innovative Solutions To The Market One Of Alexza S Key Products Is Adasuvea Staccato Loxapine Which Is Approved In 42 Countries For Managing Agitation Associated With Schizophrenia Or Bipolar I Disorderthe Company Also Has A Promising Pipeline That Includes Staccato Apomorphine For Parkinsonae S Diseasestaccato Alprazolam For Epileptic Seizuresstaccato Fentanyl For Cancer Painand Staccato Granisetron For Cyclic Vomiting Syndromethe Staccato System Allows For Rapid Absorption Of Medication Through Inhalationenhancing Treatment Efficacy Ferrer Plays A Significant Role In Alexza S Commercialization Efforts Outside The U S Utilizing Its Extensive Global Network To Market Adasuve And Support The Development Of New Therapies
